US equities |
MU $931.24 ▲+1.87% NVDA $217.23 ▼-1.84% SNDK $1,394.83 ▼-0.61% AMD $562.23 ▼-1.50% SPCX $148.62 ▼-2.33% INTC $95.37 ▼-2.80% AAPL $342.00 ▼-0.28% MSFT $539.44 ▲+1.08%
FinancialContent

Articles published by Scorpius Holdings, Inc.

News headline image
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
From Scorpius Holdings, Inc.
Via GlobeNewswire
Tickers SCPX
News headline image
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
From Scorpius Holdings, Inc.
Via GlobeNewswire
Tickers SCPX
News headline image
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Cancels Planned Reverse Stock Split
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Reverse Stock Split
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Partnership with U.S. Biotech Company
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings, Inc. Announces Closing of Public Offering
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings, Inc. Announces Pricing of Public Offering
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Reverse Stock Split
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
From Scorpius Holdings, Inc.
Via GlobeNewswire
News headline image
Scorpius Holdings, Inc. Announces Closing of Public Offering
From Scorpius Holdings, Inc.
Via GlobeNewswire